October 2011 posts
As parents, we want to do everything we can to help our children be happy, healthy, smart, and successful to give them the best chance at being happy, healthy, smart, successful adults. Especially with a first baby, we tend to listen to all sorts of sources, family, friends, and even marketing to find out what we should do and buy.
Retail stores will try to sell you tons of stuff and we often times will buy it because we don’t want to look like we don’t know what we’re doing. So, we buy the toys that have flashing lights with buttons that play Mozart, and the ones that teach infants higher math because we think we should. After you spend all the money and get the present back home, all your child wants to do is play with the box. How frustrating is that? The parents end up spending more time with the toy trying to entice the child to come play. Why do babies love playing in boxes?
This is what I call Baby Physics. They’re ‘real world’ items. They can crawl in and out. Toys can disappear only to reappear again. The sides and corners are planes and angles. Just like playing with ...
What stage is my cancer, doc?
This is often the first question we get asked when meeting with a patient newly diagnosed with lung cancer. In this blog, I would like to briefly review the notion of lung cancer staging and its implications.
Staging allows us to define the extent of a cancer and determine its best available treatment. It also allows us to statistically estimate the prognosis of the cancer. Finally, adequate staging allows us to group patients with cancers of similar extent across different institutions or even countries and evaluate the efficacy of the treatment strategies and compare with new ones.
Staging can be clinical or pathological. Clinical staging is based on the information we obtain from X-rays and scans as well as from procedures where samples (biopsies) of different tissues are obtained in an effort determine what structures may be involved with the cancer. Pathological staging is only available when the cancer has been removed by surgery: i.e. when the pathologist has measured the size of the tumor, its extent and whether or not any lymph nodes were involved with cancer. One should be aware that pathological and clinical stagings don’t always concord 100%. Sometimes clinical staging under-evaluates how extensive the cancer may be, and at times it over-evaluates it, particularly when clinical staging is based only on X-ray information. This is particularly true with the evaluation of lymph nodes that drain the area where the cancer has come from. The role of your lung cancer surgeon in adequately gathering that information to develop the best treatment plan cannot be emphasized enough.
The system we use to define a stage is called the TNM system.
Swedish is Working with Planned Parenthood of the Great Northwest to Establish Health Center on First Hill
SEATTLE, OCT. 14, 2011 — Swedish Health Services (SHS) and Planned Parenthood of the Great Northwest (PPGNW) announced today that Planned Parenthood will establish a health center on First Hill in order to provide women in the area a full range of reproductive health services, including abortion.
Our children face all sorts of challenges. Challenges at school, at home, with friends and with siblings. Challenges that are self-imposed (questions about worth, and self-doubt) and challenges of just sorting out this big world.
As parents, we’re there when they take their first breath. We help them thrive and exist as an individual being. We help them take their first steps. We cheer when they are happy and we experience physical pain when they are hurt, sad or heartbroken.
We know our child’s personality better than anyone else in the world. We know what scares them and what makes them happy. We know their likes and dislikes. We can see when they’re getting tired or hungry. We know them better than we know ourselves.
If a child then develops a problem ...
Swedish Neuroscience Institute was awarded a 7-year, $2.2M grant by the National Institute of Neurological Disease and Stroke (NINDS) to participate in the NeuroNEXT program, a national consortium of 25 neuroscience centers of excellence that will conduct early-stage clinical trials. John W. Henson, MD, FAAN, and Daniel S. Rizzuto, PhD, will lead the effort at Swedish. Swedish Neuroscience Institute was the only non-university hospital chosen to participate, highlighting the value of Swedish’s investments in research and clinical infrastructure. For more information about NeuroNEXT click here